The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Orchard Therapeutics plc(NASDAQ:ORTX) 
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified...
Website: http://www.orchard-tx.com
Founded: 2015
Full Time Employees: 252
Sector: Healthcare
Industry: Biotechnology
Orchard Therapeutics plc Days Payable Outstanding ttm (DPO)
Orchard Therapeutics plc Days Receivable Outstanding ttm (DSO)
Orchard Therapeutics plc Days Inventory Outstanding ttm (DIO)
Orchard Therapeutics plc Op Cashflow Per Share ttm
Orchard Therapeutics plc Free Cashflow Per Share ttm
Orchard Therapeutics plc Cash Per Share ttm
Orchard Therapeutics plc P/S ratio ttm
Orchard Therapeutics plc (GAAP) P/E ratio ttm
Orchard Therapeutics plc P/B ratio ttm
No extra charts and metrics for this ticker.